{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T05:01:20Z","timestamp":1788930080723,"version":"build-2803163510"},"reference-count":29,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T00:00:00Z","timestamp":1670284800000},"content-version":"unspecified","delay-in-days":5,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["RMD Open"],"accepted":{"date-parts":[[2022,11,15]]},"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1136\/rmdopen-2022-002774","type":"journal-article","created":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T09:35:56Z","timestamp":1670319356000},"page":"e002774","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Is there room for better screening for lung cancer in rheumatoid arthritis?"],"prefix":"10.1136","volume":"8","author":[{"given":"Chrysoula G","family":"Gialouri","sequence":"first","affiliation":[{"name":"Joint Academic Rheumatology Program, 2nd Department of Medicine and Laboratory, General Hospital of Athens \u201cHippokration\u201d, National and Kapodistrian University of Athens, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4932-7023","authenticated-orcid":false,"given":"George E","family":"Fragoulis","sequence":"additional","affiliation":[{"name":"Joint Academic Rheumatology Program, First Department of Propaedeutic Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,12,6]]},"reference":[{"key":"2025090313051693000_8.2.e002774.1","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1093\/rheumatology\/keac134","article-title":"Comorbidities or extra-articular manifestations: time to reconsider the terminology?","volume":"61","author":"Dey","year":"2022","journal-title":"Rheumatology"},{"key":"2025090313051693000_8.2.e002774.2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kes262"},{"key":"2025090313051693000_8.2.e002774.3","doi-asserted-by":"crossref","DOI":"10.1093\/rap\/rkac075","article-title":"Long-term outcomes in Rheumatoid Arthritis: Review of data from the 'Basildon Inflammatory Arthritis Cohort'","volume":"6","author":"Jain","year":"2022","journal-title":"Rheumatol Adv Pract"},{"key":"2025090313051693000_8.2.e002774.4","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1002\/acr.23548","article-title":"Causes of death in rheumatoid arthritis: how do they compare to the general population?","volume":"70","author":"Widdifield","year":"2018","journal-title":"Arthritis Care Res"},{"key":"2025090313051693000_8.2.e002774.5","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-015-0728-9"},{"key":"2025090313051693000_8.2.e002774.6","doi-asserted-by":"publisher","DOI":"10.1002\/art.22527"},{"key":"2025090313051693000_8.2.e002774.7","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s10067-019-04882-x","article-title":"Lung cancer in rheumatoid arthritis. is there a need for better risk assessment and screening?","volume":"39","author":"Fragoulis","year":"2020","journal-title":"Clin Rheumatol"},{"key":"2025090313051693000_8.2.e002774.8","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph10093886"},{"key":"2025090313051693000_8.2.e002774.9","doi-asserted-by":"crossref","first-page":"18001","DOI":"10.1038\/nrdp.2018.1","article-title":"Rheumatoid arthritis","volume":"4","author":"Smolen","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"2025090313051693000_8.2.e002774.10","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2019.102392","article-title":"An overview of autoantibodies in rheumatoid arthritis","volume":"110","author":"van Delft","year":"2020","journal-title":"J Autoimmun"},{"key":"2025090313051693000_8.2.e002774.11","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-208216"},{"key":"2025090313051693000_8.2.e002774.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2018.12.010"},{"key":"2025090313051693000_8.2.e002774.13","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhazmat.2022.128937","article-title":"Air pollution: a culprit of lung cancer","volume":"434","author":"Xue","year":"2022","journal-title":"J Hazard Mater"},{"key":"2025090313051693000_8.2.e002774.14","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000010071","article-title":"Prevalence of lung cancer in patients with interstitial lung disease is higher than in those with chronic obstructive pulmonary disease","volume":"97","author":"Jung","year":"2018","journal-title":"Medicine"},{"key":"2025090313051693000_8.2.e002774.15","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1093\/rheumatology\/keaa516","article-title":"Treating interstitial lung disease in rheumatoid arthritis - the embers of hope","volume":"59","author":"Conway","year":"2020","journal-title":"Rheumatology"},{"key":"2025090313051693000_8.2.e002774.16","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02154-2019","article-title":"The associations of interstitial lung abnormalities with cancer diagnoses and mortality","volume":"56","author":"Axelsson","year":"2020","journal-title":"Eur Respir J"},{"key":"2025090313051693000_8.2.e002774.17","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s10067-018-4382-x","article-title":"Risk factors for progression and prognosis of rheumatoid arthritis-associated interstitial lung disease: single center study with a large sample of Chinese population","volume":"38","author":"Fu","year":"2019","journal-title":"Clin Rheumatol"},{"key":"2025090313051693000_8.2.e002774.18","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3389\/fmed.2019.00238","article-title":"Methotrexate-Associated pneumonitis and rheumatoid Arthritis-Interstitial lung disease: current concepts for the diagnosis and treatment","volume":"6","author":"Fragoulis","year":"2019","journal-title":"Front Med"},{"key":"2025090313051693000_8.2.e002774.19","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.berh.2019.03.011","article-title":"Malignancy and rheumatoid arthritis: epidemiology, risk factors and management","volume":"32","author":"De Cock","year":"2018","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"2025090313051693000_8.2.e002774.20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2109927"},{"key":"2025090313051693000_8.2.e002774.21","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1093\/rheumatology\/keab570","article-title":"Short- and longer-term cancer risks with biologic and targeted synthetic disease-modifying antirheumatic drugs as used against rheumatoid arthritis in clinical practice","volume":"61","author":"Huss","year":"2022","journal-title":"Rheumatology"},{"key":"2025090313051693000_8.2.e002774.22","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20218"},{"key":"2025090313051693000_8.2.e002774.23","doi-asserted-by":"publisher","DOI":"10.1054\/bjoc.2001.1943"},{"key":"2025090313051693000_8.2.e002774.24","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.07.1381"},{"key":"2025090313051693000_8.2.e002774.25","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2022-002465"},{"key":"2025090313051693000_8.2.e002774.26","first-page":"261","article-title":"Immunological effects of silica and asbestos","volume":"4","author":"Otsuki","year":"2007","journal-title":"Cell Mol Immunol"},{"key":"2025090313051693000_8.2.e002774.27","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1102873"},{"key":"2025090313051693000_8.2.e002774.28","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1911793"},{"key":"2025090313051693000_8.2.e002774.29","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41571-020-00432-6","article-title":"Lung cancer LDCT screening and mortality reduction - evidence, pitfalls and future perspectives","volume":"18","author":"Oudkerk","year":"2021","journal-title":"Nat Rev Clin Oncol"}],"container-title":["RMD Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/rmdopen-2022-002774","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T20:05:23Z","timestamp":1756929923000},"score":1,"resource":{"primary":{"URL":"https:\/\/rmdopen.bmj.com\/lookup\/doi\/10.1136\/rmdopen-2022-002774"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":29,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,12,6]]},"published-print":{"date-parts":[[2022,12]]}},"alternative-id":["10.1136\/rmdopen-2022-002774"],"URL":"https:\/\/doi.org\/10.1136\/rmdopen-2022-002774","relation":{},"ISSN":["2056-5933"],"issn-type":[{"value":"2056-5933","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12]]}}}